Not applicableStudy completedNCT00938444What this trial is testingEvaluation of the BRADA and ABILHAND QuestionnairesWho this might be right forRheumatoid Arthritis University Hospital, Ghent 80
Large-scale testing (Phase 3)Study completedNCT00951275What this trial is testingTocilizumab + DMARDs in Patients With Moderate to Severe Active Rheumatoid ArthritisWho this might be right forRheumatoid Arthritis Hoffmann-La Roche 105
Testing effectiveness (Phase 2)Study completedNCT05848258What this trial is testingAn Adaptive Phase 2a/2b Study of LY3871801 in Adult Participants With Rheumatoid ArthritisWho this might be right forRheumatoid Arthritis Eli Lilly and Company 164
Large-scale testing (Phase 3)Study completedNCT01885078What this trial is testingAn Extension Study in Participants With Moderate to Severe Rheumatoid ArthritisWho this might be right forRheumatoid Arthritis Eli Lilly and Company 2,877
Large-scale testing (Phase 3)Study completedNCT03016013What this trial is testingThe Efficacy and Safety of TACI-antibody Fusion Protein Injection (RC18) in Subjects with Inadequate Response to MTX Due to Treat Moderate and Severe Rheumatoid Arthritis.Who this might be right forModerate and Severe RheumatoId Arthritis RemeGen Co., Ltd. 479
Post-approval studies (Phase 4)Looking for participantsNCT07554820What this trial is testingMajor Adverse Cardiovascular Events (MACE) in Rheumatoid Arthritis Patient With Moderate to Severe Disease Activity Treated With Tofacitinib and Statins vs TNF Inhibitors: TOFSTAT CLINICAL TRIALWho this might be right forRheumatoid ArthritisMajor Adverse Cardiac Events Shaikh Zayed Hospital, Lahore 120
Large-scale testing (Phase 3)Ended earlyNCT01202773What this trial is testingA Study in Participants With Rheumatoid ArthritisWho this might be right forRheumatoid Arthritis Eli Lilly and Company 456
Not applicableUnknownNCT04134169What this trial is testingLong-term Observational Study to Evaluation the Safety of FURESTEM-RA Inj(K0202)Who this might be right forRheumatoid Arthritis Kang Stem Biotech Co., Ltd. 28
Large-scale testing (Phase 3)Study completedNCT01895309What this trial is testingA Study Comparing SB4 to Enbrel® in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate TherapyWho this might be right forRheumatoid Arthritis Samsung Bioepis Co., Ltd. 596
Large-scale testing (Phase 3)Ended earlyNCT01665430What this trial is testingA Long-Term Extension Study to WA19926 (NCT01007435) of Tocilizumab in Participants With Early, Moderate to Severe Rheumatoid ArthritisWho this might be right forRheumatoid Arthritis Hoffmann-La Roche 38
Large-scale testing (Phase 3)Study completedNCT01258712What this trial is testingStudy of Tocilizumab in Combination With Methotrexate for Treatment of Moderate to Severe Rheumatoid Arthritis PatientsWho this might be right forRheumatoid Arthritis (RA) Chugai Pharma Taiwan 86
Large-scale testing (Phase 3)UnknownNCT05725434What this trial is testingEvaluate Usability of Subcutaneous Auto-injector of CT-P47 in Patients With Active Rheumatoid ArthritisWho this might be right forRheumatoid Arthritis Celltrion 30
Testing effectiveness (Phase 2)Ended earlyNCT01612377What this trial is testingLong Term Safety Trial of z102 and Prednisone in Patients With Moderate to Severe Rheumatoid ArthritisWho this might be right forRheumatoid Arthritis Zalicus 18
Large-scale testing (Phase 3)Study completedNCT01256736What this trial is testingTo Evaluate 1 Year Extension Study of the Efficacy and Safety of Tocilizumab in Patients With Moderate to Severe Rheumatoid ArthritisWho this might be right forRheumatoid Arthritis JW Pharmaceutical 89
Post-approval studies (Phase 4)Ended earlyNCT01927757What this trial is testingEvaluating Etanercept Use in Patients With Moderate to Severe Rheumatoid Arthritis Who Have Lost Response to AdalimumabWho this might be right forModerate to Severe Rheumatoid Arthritis Amgen 90
Testing effectiveness (Phase 2)Study completedNCT06800157What this trial is testingStudy of LW402 Tablets in Moderate to Severe Rheumatoid ArthritisWho this might be right forArthritis, Rheumatoid Shanghai Longwood Biopharmaceuticals Co., Ltd. 72
Very early researchLooking for participantsNCT07001956What this trial is testingThe Clinical Study on the Treatment of Refractory RA With UTAA91 InjectionWho this might be right forRheumatoid Arthritis (RA) Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 24
Large-scale testing (Phase 3)Study completedNCT02889796What this trial is testingFilgotinib in Combination With Methotrexate in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to MethotrexateWho this might be right forRheumatoid Arthritis Gilead Sciences 1,759
Post-approval studies (Phase 4)Study completedNCT03608761What this trial is testingComparison Between Rebamipide 2% Versus Autologous SerumWho this might be right forDry Eye SyndromesSjögren Syndrome Hospital Nacional Profesor Alejandro Posadas 21
Testing effectiveness (Phase 2)Looking for participantsNCT07137598What this trial is testingAssess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)Who this might be right forRheumatoid Arthritis Hoffmann-La Roche 160